组成的结构性大脑特征捕捉阿尔茨海默氏症的遗传风险在疾病连续性沿着大脑结构
medRxiv : the preprint server for health sciences
|May 20, 2024
概括
遗传因素在阿尔茨海默氏症 (AD) 阶段影响大脑结构. 独特的大脑特征区分健康个体与阿尔茨海默氏症患者,突出显示大脑结构和遗传风险之间的复杂相互作用.
科学领域:
- 神经成像遗传学 神经成像遗传学
- 阿尔茨海默氏症疾病研究研究
- 大脑架构 分析 分析
背景情况:
- 传统研究侧重于区域大脑体积,忽视了复杂的大脑结构和遗传影响.
- 遗传因素在大脑结构中起着至关重要的作用,但它们在阿尔茨海默氏病连续性中的影响需要进一步调查.
研究的目的:
- 调查遗传易感性如何影响阿尔茨海默病 (AD) 连续体内的大脑体积变化.
- 使用组合数据分析,区分认知无障碍 (CU) 粉样蛋白阴性个体和各种AD阶段的个体之间的大脑特征.
主要方法:
- 在AD连续体中对ALFA和ADNI研究参与者数据的分析.
- 构成数据分析的应用,以评估相对的大脑体积变化.
- 利用多基因风险评分来评估对AD的遗传易感性.
主要成果:
- 确定了明确的大脑特征,使CU粉样蛋白阴性个体与轻度认知障碍 (MCI) 和AD个体区别开来.
- 观察到疾病阶段特定的大脑特征与AD的遗传风险增加有关.
- 显示大脑结构与粉样蛋白状况和疾病进展相关的显著差异.
结论:
- 研究结果显示,在塑造大脑结构时,遗传倾向和AD疾病阶段之间的复杂相互作用.
- 与遗传风险相关的大脑特征可以为临床前阿尔茨海默病的有针对性的预防策略提供信息.
- 了解这些基因与大脑的相互作用对于开发神经退行性疾病的新型干预措施至关重要.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.9K
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.3K
相关概念视频
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Dementia
111
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
111
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
